LYNN BEARD: Open Payments
NPI 1679502801 · WILLARD, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$117 in 6 payments from 5 companies in 2025. Trend: 2023 $181 · 2024 $139 · 2025 $117
Food & beverage: $117
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| Indivior Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: VRAYLAR, ENTRESTO, OTEZLA, SUBLOCADE, SHINGRIX.
Industry payments across UT — which companies pay providers there.
